About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Aug 21, 2007... REHOVOT, ISRAEL—August 21, 2007—Chronic lymphocytic leukemia is a type of blood cancer in which specific white blood cells, called B lymphocytes or B cells, build up in the blood, bone marrow, and lymph nodes. The lifespan of a normal B cell is limited by an internal self-destruct program but, in cancer cells, this mechanism breaks down. B cells that don’t self-destruct can live on to multiply and eventually accumulate in dangerous amounts.
https://www.weizmann-usa.org/news-media/feature-stories/predicting-who-will-get-leukemia/
Jan 28, 2020...
Acute myeloid leukemia (AML), a cancer of the blood and bone marrow, is usually only diagnosed at an advanced stage, at which point it requires aggressive treatment. Although AML is a relatively rare disease, accounting for just 1.8 percent of cancer deaths in the U.S., its incidence is expected to increase as the population ages. The average age of diagnosis is 68.
“What’s horrible about AML is that often there are no symptoms or very mild symptoms, and it’s discovered during a routine blood test, meaning it’s identified when it is at a very late stage,” says Dr. Liran Shlush of the Weizmann Institute of Science’s Department of Immunology.
©2023 American Committee for the Weizmann Institute of Science
